Loading...
Docoh

Cytrx (CYTR)

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Company profile

Ticker
CYTR
Exchange
Website
CEO
Steven A. Kriegsman
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
Centurion BioPharma Corporation ...
IRS number
581642750

CYTR stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

11 Aug 22
12 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 4.11M 4.11M 4.11M 4.11M 4.11M 4.11M
Cash burn (monthly) 321.96K 360.25K 382.68K 1M 254.44K 1.08M
Cash used (since last report) 467.68K 523.29K 555.87K 1.46M 369.6K 1.56M
Cash remaining 3.64M 3.59M 3.56M 2.65M 3.74M 2.55M
Runway (months of cash) 11.3 10.0 9.3 2.6 14.7 2.4

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
10 Jan 22 Stephen Snowdy Stock Appreciation Right Common Stock Grant Acquire A No No 0.641 300,000 192.3K 300,000
15 Dec 21 Simpson Jennifer K. Common Stock Grant Acquire A No No 0 25,000 0 25,000
15 Dec 21 Simpson Jennifer K. Stock Appreciation Right Common Stock Grant Acquire A No No 0.45 50,000 22.5K 50,000
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
Coll freshman Bad
New words: aberrant, absolute, abundant, Additionally, assumption, automatically, binding, Bio, cell, central, chemotherapy, CNS, death, Denmark, detect, detected, Eastern, economy, error, excellent, experimental, experimentation, fraud, GLP, GmbH, Good, growth, horse, Immunity, immunotherapy, inflation, inflationary, inside, interval, KemPharm, maintenance, matter, met, nutritional, parallel, past, plasma, protein, pursue, put, question, range, rare, run, sarcoma, showing, signaling, Society, specialty, structure, transport, trojan, uncommon, vascular, wholly
Removed: accumulation, antibody, cytotoxic, efficacy, enhance, enrollment, failed, fully, gastrointestinal, highlighted, Kriegsman, located, medicine, personalized, Steven, testing, therapeutic